BIIB Jan 2026 380.000 call
| Previous close | 5.0000 |
| Open | 8.7800 |
| Bid | 0.0000 |
| Ask | 10.0000 |
| Strike | 380.00 |
| Expiry date | 2026-01-16 |
| Day's range | 5.0000 - 8.7800 |
| Contract range | N/A |
| Volume | |
| Open interest | 3 |
GlobeNewswireBiogen Board Appoints Two New Independent Directors
Dr. Lloyd Minor and Prof Sir Menelas Pangalos bring significant scientific expertise and considerable experience in medicine research and developmentCAMBRIDGE, Mass., Sept. 12, 2024 (GLOBE NEWSWIRE) -- The Biogen Inc. (Nasdaq: BIIB) Board of Directors (the “Board”) today announced the appointments of two new independent directors, Lloyd B. Minor, M.D., effective October 1, 2024, and Sir Menelas (Mene) Pangalos, Ph.D., effective January 1, 2025. Dr. Minor is currently the Dean of the Stanford Uni
ZacksAmgen (AMGN) Up 5.8% Since Last Earnings Report: Can It Continue?
Amgen (AMGN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
ZacksBiogen's Phase II/III SMA Study for Higher Spinraza Dose Meets Goals
BIIB's pivotal mid to late-stage study evaluating a higher dosing regimen for Spinraza to treat SMA in infants meets the primary and secondary goals.
